Literature DB >> 34565606

Hypertensive Diseases in Pregnancy and Kidney Function Later in Life: The Genetic Epidemiology Network of Arteriopathy (GENOA) Study.

Adebamike A Oshunbade1, Seth T Lirette2, B Gwen Windham3, Tariq Shafi4, Arsalan Hamid1, Semiu O Gbadamosi5, Adrienne Tin3, Wondwosen K Yimer2, Martin Tibuakuu6, Donald Clark1, Daisuke Kamimura7, Elizabeth A Lutz8, Robert J Mentz9, Ervin R Fox1, Javed Butler1, Kenneth R Butler3, Vesna D Garovic10, Stephen T Turner11, Thomas H Mosley3, Michael E Hall12.   

Abstract

OBJECTIVE: To evaluate the relationship between hypertensive diseases in pregnancy and kidney function later in life.
METHODS: We evaluated measured glomerular filtration rate (mGFR) using iothalamate urinary clearance in 725 women of the Genetic Epidemiology Network of Arteriopathy (GENOA) study. Women were classified by self-report as nulliparous (n=62), a history of normotensive pregnancies (n=544), a history of hypertensive pregnancies (n=102), or a history of pre-eclampsia (n=17). We compared adjusted associations among these four groups with mGFR using generalized estimating equations to account for familial clustering. Chronic kidney disease (CKD) was defined as mGFR of less than 60 mL/min per 1.73 m2 or urinary albumin-creatinine ratio (UACR) greater than or equal to 30 mg/g.
RESULTS: Among women with kidney function measurements (mean age, 59±9 years, 52.9% African American), those with a history of hypertensive pregnancy had lower mGFR (-4.66 ml/min per 1.73 m2; 95% CI, -9.12 to -0.20) compared with women with a history of normotensive pregnancies. Compared with women with a history of normotensive pregnancies, women with a history of hypertensive pregnancy also had higher odds of mGFR less than 60 ml/min per 1.73 m2 (odds ratio, 2.09; 95% CI, 1.21 to 3.60). Additionally, women with a history of hypertensive pregnancy had greater odds for chronic kidney disease (odds ratio, 4.89; 95% CI, 1.55 to 15.44), after adjusting for age, race, education, smoking history, hypertension, body mass index, and diabetes.
CONCLUSION: A history of hypertension in pregnancy is an important prognostic risk factor for kidney disease. To our knowledge, this is the first and largest investigation showing the association between hypertensive diseases in pregnancy and subsequent kidney disease using mGFR in a large biracial cohort.
Copyright © 2021. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2021        PMID: 34565606      PMCID: PMC9031057          DOI: 10.1016/j.mayocp.2021.07.018

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   11.104


  30 in total

1.  Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births.

Authors:  G C Smith; J P Pell; D Walsh
Journal:  Lancet       Date:  2001-06-23       Impact factor: 79.321

2.  GFR determined by nonradiolabeled iothalamate using capillary electrophoresis.

Authors:  D M Wilson; J H Bergert; T S Larson; R R Liedtke
Journal:  Am J Kidney Dis       Date:  1997-11       Impact factor: 8.860

3.  Measured Versus Estimated Glomerular Filtration Rate in the Assessment of Living Kidney Donors: eGFR Has Its Limitations.

Authors:  Iain A M MacPhee
Journal:  Transplantation       Date:  2018-10       Impact factor: 4.939

4.  Higher plasma leptin levels are associated with reduced left ventricular mass and left ventricular diastolic stiffness in black women: insights from the Genetic Epidemiology Network of Arteriopathy (GENOA) study.

Authors:  Daisuke Kamimura; Takeki Suzuki; Wanmei Wang; Matthew deShazo; John E Hall; Michael D Winniford; Iftikhar J Kullo; Thomas H Mosley; Kenneth R Butler; Michael E Hall
Journal:  Hypertens Res       Date:  2018-06-15       Impact factor: 3.872

Review 5.  Preeclampsia and future cardiovascular risk: formal risk factor or failed stress test?

Authors:  Iasmina Craici; Steven Wagner; Vesna D Garovic
Journal:  Ther Adv Cardiovasc Dis       Date:  2008-08

6.  A genome-wide scan for urinary albumin excretion in hypertensive families.

Authors:  Barry I Freedman; Stephanie R Beck; Stephen S Rich; Gerardo Heiss; Cora E Lewis; Stephen Turner; Michael A Province; Karen L Schwander; Donna K Arnett; Beverly G Mellen
Journal:  Hypertension       Date:  2003-08-18       Impact factor: 10.190

7.  Death rates from ischemic heart disease in women with a history of hypertension in pregnancy.

Authors:  L S Jónsdóttir; R Arngrímsson; R T Geirsson; H Sigvaldason; N Sigfússon
Journal:  Acta Obstet Gynecol Scand       Date:  1995-11       Impact factor: 3.636

Review 8.  Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses.

Authors:  Sarah D McDonald; Ann Malinowski; Qi Zhou; Salim Yusuf; Philip J Devereaux
Journal:  Am Heart J       Date:  2008-10-02       Impact factor: 4.749

Review 9.  Measured and estimated glomerular filtration rate: current status and future directions.

Authors:  Andrew S Levey; Josef Coresh; Hocine Tighiouart; Tom Greene; Lesley A Inker
Journal:  Nat Rev Nephrol       Date:  2019-09-16       Impact factor: 28.314

Review 10.  Pathophysiology of placentation abnormalities in pregnancy-induced hypertension.

Authors:  Mitsuko Furuya; Junji Ishida; Ichiro Aoki; Akiyoshi Fukamizu
Journal:  Vasc Health Risk Manag       Date:  2008
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.